Angel News


Back to Homepage

19th March 2021

How the life science sector has shot up the investment agenda as vaccinations are rolled out

Andrew Aldridge, Partner at Deepbridge Capital, discusses why the life sciences sector is now back in favour with investors.

The past twelve months have showcased the importance of medical developments like never before. Innovation in the life sciences sector has been headline news around the globe and all aspects of the healthcare system have been under the microscope. Not only the direct response to the global pandemic, with vaccinations and treatments, but also the importance of mental health, the care home profession, screening programmes and telemedicine, have had the spotlight shone on them. 


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage